VENICE, FL--(Marketwire - December 14, 2009) -
SinoFresh Healthcare, Inc., (PINKSHEETS: SFSH
announced the recent successful initial animal pilot study of the SinoFresh
Nasal Spray product for use in preventing and decreasing the severity of
H1N1 ("swine flu") virus. Additional testing necessary for FDA approval of
the product for this use, as well as a product specifically targeted at
cold and flu including H1N1, is planned. The study suggests that SinoFresh
Nasal Spray use allowed the H1N1 infected animals to recover more rapidly
than did untreated animals.
The study conducted by SRS International Corp. of Falls Church, VA was
designed to evaluate the severity of infection from H1N1 ("swine flu")
virus in a well accepted rodent model for studying human nasal and
respiratory tract infection by viruses and other microbial pathogens. In
the study, the test animals were inoculated with H1N1 and then received
SinoFresh Nasal Spray in the nose three times daily for 14 days.
Dr. John A. Todhunter, President of SRS International, who conducted the
testing said, "We believe that SinoFresh Homeopathic Antiseptic Nasal
Spray's current and past test results supporting a broad killing capability
against numerous viruses, bacteria and other pathogens should make the
product an excellent candidate for eventual evaluation by the FDA as a
safe, broad based preventative antiseptic nasal and sinus cleansing
product, which could be used by consumers to enhance current disease
prevention measures such as using hand sanitizers and antiseptic
Drs. Michael Stampar, D.O. and Cathy Criss, D.O., Senior Medical Advisors
to the Company stated, "In our opinion, these test results are consistent
with our nearly eight years of clinical experience and observations using
SinoFresh. When coupled with prior SinoFresh testing results, it further
confirms our belief that SinoFresh Homeopathic Antiseptic Nasal Spray is on
track to be recognized as a breakthrough solution in helping to prevent
and/or reduce the severity of a broad range of upper respiratory infections
caused by airborne pathogens."
About SinoFresh™ HealthCare, Inc.
SinoFresh™ HealthCare, Inc. is a developer and marketer of therapies to
treat inflammatory and infectious diseases of the upper respiratory system.
The Company is researching broad-spectrum antiseptic approaches to reducing
viral, bacterial and fungal organisms suspected of causing pathogenesis of
the mouth nose and throat. The Company holds certain patents and patent
applications on its innovative pharmaceutical technology and relies upon a
panel of medical experts and management team experienced in the
The Company's product, SinoFresh™ Nasal & Sinus Care, is the only
over-the-counter antiseptic nasal spray that kills bacteria and fungi and
viral pathogens in the throat and nasal passages. The Company is also
researching how antiseptic cleansing may aid in alleviating sinus distress,
a problem that affects many Americans annually. More information is
available at www.sinofresh.com.
*SinoFresh™ is a trademark of SinoFresh HealthCare, Inc.
Follow us on Twitter. Become a fan on Facebook.
For further information company can be contacted at 888-460-4774, or on the
web at www.sinofreshproducts.com, or by email at
Except for the historical information contained herein, this press release
contains forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. Any
forward-looking statements speak only as of the date on which such
statements are made and involve risks and uncertainties detailed in the
Company's filings with the Securities and Exchange commission, including
risks summarized in the company's annual Report of form 10-KSB for its
fiscal year ended December 31, 2006 (file No.49764). The Company's actual
results could differ materially from such forward-looking statements. The
Company undertakes no obligation to update any forward-looking statement or
statements to reflect new events or circumstances or future developments.